Background The replication-competent recombinant vesicular stomatitis virus (rVSV)–based
vaccine expressing a Zaire ebolavirus (ZEBOV) glycoprotein was selected for rapid safety …

Background The RTS,S/AS01 vaccine targets the circumsporozoite protein of Plasmodium
falciparum and has partial protective efficacy against clinical and severe malaria disease in …

Background The RTS,S/AS01 malaria vaccine targets the circumsporozoite protein,
inducing antibodies associated with the prevention of Plasmodium falciparum infection. We …

Introduction Malaria, a devastating febrile illness caused by protozoan parasites, sickened
247,000,000 people in 2021 and killed 619,000, mostly children and pregnant women in sub-…

The first clinical Phase III trial evaluating a malaria vaccine was completed in December
2013 at 11 sites from seven sub-Saharan African countries. This systematic review assesses …

Background . Plasmodium falciparum infection during pregnancy is associated with stillbirth,
fetal growth restriction, and low birth weight. An additional consequence may be increased …

distancing interventions, including nationwide school closures and cancellation of public
gatherings, was associated with a 30% reduction in the transmission rate. 10 However, it …

Pregnancy-associated malaria is one of the leading causes of low birth weight in malaria
endemic areas. In this study, 145 parturient women residing in areas endemic for Plasmodium …

Objectives To evaluate the epidemiologic data of parasitic infections and co‐infections in
pregnant women in Lambaréné, Gabon. Methods In Lambaréné, Gabon – a region of high …

Background The efficacy of RTS,S/AS01 as a vaccine for malaria is being tested in a phase
3 clinical trial. Early results show significant, albeit partial, protection against clinical malaria …